Theoretical Concerns
In 1984, Stegink and Filer (3) edited a 670-page book on aspartame,
withonly one clinical reference to seizures (on page 419), despite nine chapters reviewing possible side-effects of aspartame. Since that time, several reports of animal studies and anecdotal clinical cases have appeared to consider a relationship between aspartame and seizures. Aspartame ingestion increases the plasma concentration of the excitatory amino acids aspartate and phenylalanine, and in very high concentrations it may also increase brain concentration of phenylalanine (see above). There is no doubt that direct application of aspartate or glutamate to neurons can produce neuronal depolarization and cellular bursting in animal model systems (39). Nevertheless, it is a mistake to presume from this observation that raising the plasma concentration of aspartate or phenylalanine would be convulsant in whole organisms. First, quantities of amino acid passing the blood-brain barrier might be insufficient to excite neurons. Second, excitation of certain inhibitor neuronal pools could raise the threshold for seizures. Third, regulatory mechanisms are endemic to the brain to "dampen" the effect of excessive excitation by amino acids, such that synaptic transmission can actually be depressed by exposure to high concentrations of aspartate or glutamate for periods of a few minutes (40). Effects of a rise in plasma phenylalanine